Mordechai Applebaum

Mordechai Applebaum possesses extensive experience in the biotechnology and medical fields, currently serving as a Board Observer at Vensica Medical and ExoProTher Medical, and as a Director on the Board of CombinAble.AI. Previous roles include analyst at Israel Biotech Fund and Director of R&D at Vaxil Bio Ltd. Notably, Mordechai held key positions at Enlivex Therapeutics, contributing significantly to preclinical operations and project management. Education includes a Ph.D. in Developmental Biology and Embryology, alongside multiple degrees from The Hebrew University of Jerusalem in fields such as Medical Sciences and Philosophy. Additional experience encompasses roles in public relations, content management, and teaching at various educational institutions.